Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Exciting new developments in the treatment of multicentric Castleman disease

Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond Wong - The Chinese University of Hong Kong
Exciting new developments in the treatment of multicentric Castleman disease ( Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond Wong - The Chinese University of Hong Kong )
19 Dec 2013

New therapy aspects for myeloid chronic lymphoma

Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine
New therapy aspects for myeloid chronic lymphoma ( Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine )
19 Dec 2013

New line of therapy for acute myeloid leukaemia

Dr David Taussig - Barts Cancer Institute, London, UK
New line of therapy for acute myeloid leukaemia ( Dr David Taussig - Barts Cancer Institute, London, UK )
18 Dec 2013

Novel agent CC-292 for CLL using the B-cell receptor pathway

Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA
Novel agent CC-292 for CLL using the B-cell receptor pathway ( Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA )
18 Dec 2013

Encouraging early results with GS-9973 for CLL and NHL

Dr Jeff Sharman- US Oncology, Eugene, Oregon
Encouraging early results with GS-9973 for CLL and NHL ( Dr Jeff Sharman- US Oncology, Eugene, Oregon )
18 Dec 2013

Role of Bcl-2 family in lymphoid malignancies

Prof Andreas Strasser - University of Melbourne, Melbourne, Australia
Role of Bcl-2 family in lymphoid malignancies ( Prof Andreas Strasser - University of Melbourne, Melbourne, Australia )
18 Dec 2013

FLT3-ITD positive acute myeloid leukaemia

Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA
FLT3-ITD positive acute myeloid leukaemia ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )
18 Dec 2013

PI3K-delta inhibitor idelalisib success in CLL

Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA
PI3K-delta inhibitor idelalisib success in CLL ( Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA )
18 Dec 2013

Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma

Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France )
18 Dec 2013

T cell immunotherapy for leukaemia in preclinical setting

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
T cell immunotherapy for leukaemia in preclinical setting ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
17 Dec 2013

Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL)

Dr Richard Furman - New York Weill Cornell Medical Center, USA
Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL) ( Dr Richard Furman - New York Weill Cornell Medical Center, USA )
17 Dec 2013

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML)

Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )
17 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation